J. Beitz, C. Gnecco, and R. Justice, Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective, J Natl Cancer Inst Monogr, pp.7-9, 1996.

F. Bonnetain, C. Borg, R. R. Adams, J. A. Ajani, A. Benson et al., How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials, Ann Oncol, vol.28, pp.2077-85, 2017.

F. Joly, F. Hilpert, A. Okamoto, G. Stuart, K. Ochiai et al., Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient-reported outcomes in clinical trials in epithelial ovarian cancer, Eur J Cancer Oxf Engl, vol.78, pp.133-141, 1990.

C. C. Gotay, E. L. Korn, M. S. Mccabe, T. D. Moore, and B. D. Cheson, Building quality of life assessment into cancer treatment studies, Oncol Williston Park N, vol.6, pp.25-33, 1992.

L. Ring, S. Höfer, F. Heuston, D. Harris, O. Boyle et al., Response shift masks the treatment impact on patient reported outcomes (PROs): the example of individual quality of life in edentulous patients, Health Qual Life Outcomes, vol.3, p.55, 2005.

W. Group, Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL), Qual Life Res, vol.2, pp.153-162, 1993.

D. Osoba, Lessons learned from measuring health-related quality of life in oncology, J Clin Oncol Off J Am Soc Clin Oncol, vol.12, pp.608-624, 1994.

E. Carlens, G. Dahlström, and E. Nöu, An attempt to include "quality of life" in evaluation of survival in bronchial cancer therapy, Bronches, vol.21, pp.215-224, 1971.

P. S. Burge, T. A. Prankerd, J. D. Richards, M. Sare, D. S. Thompson et al., Quality and quantity of survival in acute myeloid leukaemia, Lancet Lond Engl, vol.2, pp.621-625, 1975.

M. Hervy, Des recommandations de l'anesm sur la qualité de vie en ehpad : pourquoi ce thème ?, Empan, pp.126-158, 2013.

, Quality of Life Assessments in Clinical Trials, 1990.

M. Oleson, Content validity of the quality of life index, Appl Nurs Res, vol.3, pp.126-133, 1990.

D. F. Cella and D. S. Tulsky, Quality of life in cancer: definition, purpose, and method of measurement, Cancer Invest, vol.11, pp.327-363, 1993.

D. A. Revicki, D. Osoba, D. Fairclough, I. Barofsky, R. Berzon et al., Recommendations on health-related quality of life research to support labeling and promotional claims in the United States, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.9, pp.887-900, 2000.

M. Bullinger, Assessing health related quality of life in medicine. An overview over concepts, methods and applications in international research, Restor Neurol Neurosci, vol.20, pp.93-101, 2002.

K. Wiklund, L. E. Holm, and G. Eklund, Cancer risks in Swedish Lapps who breed reindeer, Am J Epidemiol, vol.132, pp.1078-82, 1990.

J. Addington-hall and L. Kalra, Who should measure quality of life?, BMJ, vol.322, pp.1417-1437, 2001.

I. B. Wilson and P. D. Cleary, Linking Clinical Variables With Health-Related Quality of Life: A Conceptual Model of Patient Outcomes, JAMA, vol.273, pp.59-65, 1995.

R. Feld, Endpoints in cancer clinical trials: is there a need for measuring quality of life? Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.3, pp.23-30, 1995.

H. Schipper and M. Levitt, Measuring quality of life: risks and benefits, Cancer Treat Rep, vol.69, pp.1115-1140, 1985.

D. F. Cella, Le concept de qualité de vie : les soins palliatifs et la qualité de vie, Rech Soins Infirm, pp.25-31, 2007.

N. K. Leidy, D. A. Revicki, and B. Genesté, Recommendations for evaluating the validity of quality of life claims for labeling and promotion, Value Health J Int Soc Pharmacoeconomics Outcomes Res, vol.2, pp.113-140, 1999.

S. Wood-dauphinee, Assessing Quality of Life in Clinical Research: From Where Have We Come and Where Are We Going?, J Clin Epidemiol, vol.52, pp.355-63, 1999.

P. Gérin, A. Dazord, J. P. Boissel, M. T. Hanauer, P. Moleur et al.,

, Therapie, vol.44, pp.355-64, 1989.

C. M. Moinpour, P. Feigl, B. Metch, K. A. Hayden, F. L. Meyskens et al., Quality of life end points in cancer clinical trials: review and recommendations, vol.81, pp.485-95, 1989.

F. Bonnetain, Health related quality of life and endpoints in oncology

, Cancer Radiother J Soc Francaise Radiother Oncol, vol.14, pp.515-523, 2010.

F. Fiteni, V. Westeel, X. Pivot, C. Borg, D. Vernerey et al., Endpoints in cancer clinical trials, J Visc Surg, vol.151, pp.17-22, 2014.
URL : https://hal.archives-ouvertes.fr/tel-01579503

S. Mathoulin-pélissier-c-par-ak, Méthodes biostatistiques appliquées à la recherche clinique en cancérologie, 2018.

A. Mauguen, J. Pignon, S. Burdett, C. Domerg, D. Fisher et al., Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data, Lancet Oncol, vol.14, pp.619-645, 2013.

G. Cicero, D. Luca, R. Dieli, and F. , Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer, OncoTargets Ther, vol.11, pp.3059-63, 2018.

L. Li and Z. Pan, Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials, Clin Breast Cancer, vol.18, pp.63-70, 2018.

J. R. Johnson and R. Temple, Food and Drug Administration requirements for approval of new anticancer drugs, Cancer Treat Rep, vol.69, pp.1155-1164, 1985.

C. Alifrangis, L. Koizia, A. Rozario, S. Rodney, M. Harrington et al., The experiences of cancer patients, QJM Mon J Assoc Physicians, vol.104, pp.1075-81, 2011.

P. Wimberger, H. Gilet, A. Gonschior, M. M. Heiss, M. Moehler et al., Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone, Ann Oncol Off J Eur Soc Med Oncol, vol.23, pp.1979-85, 2012.

D. Steinmann, Y. Paelecke-habermann, H. Geinitz, R. Aschoff, A. Bayerl et al., Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases, BMC Cancer, vol.12, p.283, 2012.

J. Beitz, C. Gnecco, and R. Justice, Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective, J Natl Cancer Inst Monogr, pp.7-9, 1996.

J. E. Ware and C. D. Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Med Care, vol.30, pp.473-83, 1992.

J. E. Ware, K. K. Snow, M. Kosinski, B. Gandek, and N. Institute, SF-36 health survey: manual and interpretation guide. The Health Institute, 1993.

M. Bullinger, P. Azouvi, N. Brooks, A. Basso, A. Christensen et al., Quality of life in patients with traumatic brain injury-basic issues, assessment and recommendations, Restor Neurol Neurosci, vol.20, pp.111-135, 2002.

P. S. Chrispin, H. Scotton, J. Rogers, D. Lloyd, and S. A. Ridley, Short Form 36 in the intensive care unit: assessment of acceptability, reliability and validity of the questionnaire, Anaesthesia, vol.52, pp.15-23, 1997.

S. A. Ridley, P. S. Chrispin, H. Scotton, J. Rogers, and D. Lloyd, Changes in quality of life after intensive care: comparison with normal data, Anaesthesia, vol.52, pp.195-202, 1997.

C. R. Weinert, C. R. Gross, J. R. Kangas, C. L. Bury, and W. A. Marinelli, Health-related quality of life after acute lung injury, Am J Respir Crit Care Med, vol.156, pp.1120-1128, 1997.

G. Schelling, C. Stoll, M. Haller, J. Briegel, W. Manert et al., Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome, Crit Care Med, vol.26, pp.651-660, 1998.

E. Neugebauer, B. Bouillon, M. Bullinger, and S. Wood-dauphinée, Quality of life after multiple trauma--summary and recommendations of the consensus conference, Restor Neurol Neurosci, vol.20, pp.161-168, 2002.

W. Group, Development of the WHOQOL: Rationale and Current Status, Int J Ment Health, vol.23, pp.24-56, 1994.

, The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties, Soc Sci Med, vol.46, pp.1569-85, 1982.

V. Noerholm, M. Groenvold, T. Watt, J. B. Bjorner, N. A. Rasmussen et al., Quality of life in the Danish general population--normative data and validity of WHOQOL-BREF using Rasch and item response theory models, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.13, pp.531-571, 2004.

, Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group, Psychol Med, vol.28, pp.551-559, 1998.

E. Group, EuroQol--a new facility for the measurement of health-related quality of life, Health Policy Amst Neth, vol.16, pp.199-208, 1990.

G. Amarenco, B. Bayle, D. Lagauche, E. Lapeyre, and S. S. Ismael, Construction et validation des échelles de qualité de vie, Ann Réadapt Médecine Phys, vol.43, pp.263-272, 2000.

N. K. Aaronson, S. Ahmedzai, B. Bergman, M. Bullinger, A. Cull et al., The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology, J Natl Cancer Inst, vol.85, pp.365-76, 1993.

P. Fayers, N. K. Aaronson, K. Bjordal, M. Groenvold, D. Curran et al., EORTC QLQ-C30 Scoring Manual

, European Organisation for Research and Treatment of Cancer, 2001.

M. A. Sprangers, M. Groenvold, J. I. Arraras, J. Franklin, A. Te-velde et al., The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study, J Clin Oncol Off J Am Soc Clin Oncol, vol.14, pp.2756-68, 1996.

D. Osoba, N. K. Aaronson, M. Muller, K. Sneeuw, M. A. Hsu et al., The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.5, pp.139-50, 1996.

D. F. Cella, D. S. Tulsky, G. Gray, B. Sarafian, E. Linn et al., The Functional Assessment of Cancer Therapy scale: development and validation of the general measure, J Clin Oncol Off J Am Soc Clin Oncol, vol.11, pp.570-579, 1993.

D. Cella, Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system, Cent Outcomes Res Educ CORE, 1997.

M. J. Brady, D. F. Cella, F. Mo, A. E. Bonomi, D. S. Tulsky et al., Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument, J Clin Oncol Off J Am Soc Clin Oncol, vol.15, pp.974-86, 1997.

P. Fayers and D. Machin, Quality of Life: The Assessment, Analysis and Interpretation of Patientreported Outcomes

. Wiley and . Com, , pp.2-2, 2018.

J. Nunnally and I. Bernstein, , 1994.

F. Efficace, P. Fayers, A. Pusic, Y. Cemal, J. Yanagawa et al., Quality of Patient-Reported Outcome (PRO) Reporting Across Cancer Randomized Controlled Trials According to the CONSORT PRO Extension: A Pooled Analysis of 557 Trials, Cancer, vol.121, pp.3335-3377, 2015.

E. Vodicka, K. Kim, E. B. Devine, A. Gnanasakthy, J. F. Scoggins et al., Inclusion of patientreported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov, 2007.

, Contemp Clin Trials, vol.43, pp.1-9, 2015.

D. Osoba, G. Rodrigues, J. Myles, B. Zee, and J. Pater, Interpreting the significance of changes in health-related quality-of-life scores, J Clin Oncol, pp.139-183, 1998.

R. Jaeschke, J. Singer, and G. H. Guyatt, Measurement of health status: Ascertaining the minimal clinically important difference, Control Clin Trials, vol.10, pp.407-422, 1989.

T. Hajiro and K. Nishimura, Minimal clinically significant difference in health status: the thorny path of health status measures?, Eur Respir J, vol.19, pp.390-391, 2002.

G. Wells, D. Beaton, B. Shea, M. Boers, L. Simon et al., Minimal clinically important differences: review of methods, J Rheumatol, vol.28, pp.406-418, 2001.

R. D. Crosby, R. L. Kolotkin, and G. R. Williams, Defining clinically meaningful change in health-related quality of life, J Clin Epidemiol, vol.56, pp.395-407, 2003.

E. Lydick and R. S. Epstein, Interpretation of quality of life changes, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.2, pp.221-227, 1993.

D. Cella, D. T. Eton, J. Lai, A. H. Peterman, and D. E. Merkel, Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales, J Pain Symptom Manage, vol.24, pp.547-61, 2002.

A. G. Copay, B. R. Subach, S. D. Glassman, D. W. Polly, and T. C. Schuler, Understanding the minimum clinically important difference: a review of concepts and methods, Spine J Off J North Am Spine Soc, vol.7, pp.541-547, 2007.

K. J. Yost, D. Cella, A. Chawla, E. Holmgren, D. T. Eton et al., Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution-and anchor-based approaches, J Clin Epidemiol, vol.58, pp.1241-51, 2005.

K. J. Yost, D. T. Eton, S. F. Garcia, and D. Cella, Minimally important differences were estimated for six PROMIS-Cancer scales in advanced-stage cancer patients, J Clin Epidemiol, vol.64, pp.507-523, 2011.

J. T. Maringwa, C. Quinten, M. King, J. Ringash, D. Osoba et al., Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.19, pp.1753-60, 2011.

G. Bedard, L. Zeng, L. Zhang, N. Lauzon, L. Holden et al., Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer, Asia Pac J Clin Oncol, vol.10, pp.109-126, 2014.

E. Wong, L. Zhang, M. Kerba, P. F. Arnalot, B. Danielson et al., Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.23, pp.2731-2738, 2015.

A. Escobar, G. Pérez, L. Herrera-espiñeira, C. Aizpuru, F. Sarasqueta et al.,

M. Tejada, Total knee replacement; minimal clinically important differences and responders, Osteoarthritis Cartilage, vol.21, pp.2006-2018, 2013.

, Mind the MIC: large variation among populations and methods -ScienceDirect, 2018.

N. Der-roer, R. Ostelo, G. E. Bekkering, M. W. Van-tulder, and H. De-vet, Minimal clinically important change for pain intensity, functional status, and general health status in patients with nonspecific low back pain, Spine, vol.31, pp.578-82, 2006.

K. Mills, J. M. Naylor, J. P. Eyles, E. M. Roos, and D. J. Hunter, Examining the Minimal Important Difference of Patient-reported Outcome Measures for Individuals with Knee Osteoarthritis: A Model Using the Knee Injury and Osteoarthritis Outcome Score, J Rheumatol, vol.43, pp.395-404, 2016.

H. De-vet, B. Terluin, D. L. Knol, L. D. Roorda, L. B. Mokkink et al., Three ways to quantify uncertainty in individually applied "minimally important change" values, J Clin Epidemiol, vol.63, pp.37-45, 2010.

D. Hosmer and S. Lemeshow, Applied logistic regression, 2000.

B. Terluin, I. Eekhout, C. B. Terwee, and H. De-vet, Minimal important change (MIC) based on a predictive modeling approach was more precise than MIC based on ROC analysis, J Clin Epidemiol, vol.68, pp.1388-96, 2015.

G. R. Norman, P. Stratford, and G. Regehr, Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach, J Clin Epidemiol, vol.50, pp.869-79, 1997.

S. Raman, K. Ding, E. Chow, R. M. Meyer, Y. M. Van-der-linden et al., Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing reirradiation for painful bone metastases, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.27, pp.1089-98, 2018.

G. Bedard, L. Zeng, L. Zhang, N. Lauzon, L. Holden et al., Minimal important differences in the EORTC QLQ-C15-PAL to determine meaningful change in palliative advanced cancer patients, Asia Pac J Clin Oncol, vol.12, pp.38-46, 2016.

S. Raman, K. Ding, E. Chow, R. M. Meyer, A. Nabid et al., Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.25, pp.2535-2576, 2016.

B. L. Den-oudsten, W. P. Zijlstra, D. Vries, and J. , The minimal clinical important difference in the World Health Organization Quality of Life instrument--100, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.21, pp.1295-301, 2013.

M. T. King, The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.5, pp.555-67, 1996.

J. Ringash, A. Bezjak, B. O'sullivan, and D. A. Redelmeier, Interpreting differences in quality of life: the FACT-H&N in laryngeal cancer patients, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.13, pp.725-758, 2004.

D. Cella, D. T. Eton, D. L. Fairclough, P. Bonomi, A. E. Heyes et al., What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592, J Clin Epidemiol, vol.55, pp.285-95, 2002.

J. T. Maringwa, C. Quinten, M. King, J. Ringash, D. Osoba et al., Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.19, pp.1753-60, 2011.

A. S. Pickard, M. P. Neary, and D. Cella, Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer, Health Qual Life Outcomes, vol.5, p.70, 2007.

J. Maringwa, C. Quinten, M. King, J. Ringash, D. Osoba et al., Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients, Ann Oncol, vol.22, pp.2107-2119, 2011.

J. L. Steel, D. T. Eton, D. Cella, M. C. Olek, and B. I. Carr, Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma, Ann Oncol Off J Eur Soc Med Oncol, vol.17, pp.304-316, 2006.

Z. J. Musoro, J. Hamel, D. E. Ediebah, K. Cocks, M. T. King et al., Establishing anchorbased minimally important differences (MID) with the EORTC quality-of-life measures: a metaanalysis protocol, BMJ Open, 2018.

D. Revicki, R. D. Hays, D. Cella, and J. Sloan, Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes, J Clin Epidemiol, vol.61, pp.102-111, 2008.

E. Lydick and R. S. Epstein, Interpretation of quality of life changes, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.2, pp.221-227, 1993.

G. R. Norman, J. A. Sloan, and K. W. Wyrwich, Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation, Med Care, vol.41, pp.582-92, 2003.

D. Cella, E. A. Hahn, and K. Dineen, Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.11, pp.207-228, 2002.

G. Samsa, D. Edelman, M. L. Rothman, G. R. Williams, J. Lipscomb et al., Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II, PharmacoEconomics, vol.15, pp.141-55, 1999.

D. T. Eton, D. Cella, K. J. Yost, S. E. Yount, A. H. Peterman et al., A combination of distribution-and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale, J Clin Epidemiol, vol.57, pp.898-910, 2004.

K. W. Wyrwich, W. M. Tierney, and F. D. Wolinsky, Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life, J Clin Epidemiol, vol.52, pp.861-73, 1999.

F. D. Wolinsky, G. J. Wan, and W. M. Tierney, Changes in the SF-36 in 12 months in a clinical sample of disadvantaged older adults, Med Care, vol.36, pp.1589-98, 1998.

C. A. Mchorney and A. R. Tarlov, Individual-patient monitoring in clinical practice: are available health status surveys adequate?, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.4, pp.293-307, 1995.

A. V. Kulkarni, Distribution-based and anchor-based approaches provided different interpretability estimates for the Hydrocephalus Outcome Questionnaire, J Clin Epidemiol, vol.59, pp.176-84, 2006.

S. J. Taylor, A. E. Taylor, M. A. Foy, and A. J. Fogg, Responsiveness of common outcome measures for patients with low back pain, Spine, vol.24, pp.1805-1817, 1999.

R. D. Hays and J. M. Woolley, The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?, PharmacoEconomics, vol.18, pp.419-442, 2000.

J. Cohen, Statistical Power Analysis for the Behavioral Sciences -1st Edition

J. E. Bolton, Sensitivity and specificity of outcome measures in patients with neck pain: detecting clinically significant improvement, Spine, vol.29, pp.2410-2417, 2004.

N. S. Jacobson and P. Truax, Clinical significance: a statistical approach to defining meaningful change in psychotherapy research, J Consult Clin Psychol, vol.59, pp.12-21, 1991.

M. H. Liang, A. H. Fossel, and M. G. Larson, Comparisons of five health status instruments for orthopedic evaluation, Med Care, vol.28, pp.632-674, 1990.

D. E. Beaton, S. Hogg-johnson, and C. Bombardier, Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders, J Clin Epidemiol, vol.50, pp.79-93, 1997.

A. M. Garratt, D. A. Ruta, M. I. Abdalla, and I. T. Russell, SF 36 health survey questionnaire: II. Responsiveness to changes in health status in four common clinical conditions, Qual Health Care QHC, vol.3, pp.186-92, 1994.

G. Wells, D. Beaton, B. Shea, M. Boers, L. Simon et al., Minimal clinically important differences: review of methods, J Rheumatol, vol.28, pp.406-418, 2001.

N. Black, M. Murphy, D. Lamping, M. Mckee, C. Sanderson et al., Consensus development methods: a review of best practice in creating clinical guidelines, J Health Serv Res Policy, vol.4, pp.236-284, 1999.

H. P. Mckenna, The Delphi technique: a worthwhile research approach for nursing?, J Adv Nurs, vol.19, pp.1221-1226, 1994.

G. Wells, T. Li, L. Maxwell, R. Maclean, and P. Tugwell, Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis, J Rheumatol, vol.34, pp.280-289, 2007.

D. A. Redelmeier, G. H. Guyatt, and R. S. Goldstein, Assessing the minimal important difference in symptoms: a comparison of two techniques, J Clin Epidemiol, vol.49, pp.1215-1224, 1996.

F. Fiteni, A. Anota, V. Westeel, and F. Bonnetain, Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review, BMC Cancer, vol.16, p.122, 2016.

F. Bonnetain, L. Dahan, E. Maillard, M. Ychou, E. Mitry et al., Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma, Eur J Cancer, vol.46, pp.2753-62, 2010.

L. Awad, E. Zuber, and M. Mesbah, Applying Survival Data Methodology to Analyze Longitudinal Quality of Life Data, Stat Methods Qual Life Stud Des Meas Anal

M. A. Boston and U. S. Springer, , pp.231-274, 2002.

A. Anota, Z. Hamidou, S. Paget-bailly, B. Chibaudel, C. Bascoul-mollevi et al., Time to health-related quality of life score deterioration as a modality of longitudinal analysis for healthrelated quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.24, pp.5-18, 2015.

Z. Hamidou, T. S. Dabakuyo, M. Mercier, J. Fraisse, S. Causeret et al., Time to Deterioration in Quality of Life Score as a Modality of Longitudinal Analysis in Patients with Breast Cancer, The Oncologist, vol.16, pp.1458-68, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00687536

Y. Wu, M. M. Amonkar, B. H. Sherrill, O. Shaughnessy, J. Ellis et al., Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumabrefractory HER2+ metastatic breast cancer, Ann Oncol Off J Eur Soc Med Oncol, vol.22, pp.2582-90, 2011.

D. Fairclough, Design and Analysis of Quality of Life Studies in Clinical Trials, Interdisciplinary Statistics Series, 2002.

S. Ahmed, C. Schwartz, L. Ring, and M. Sprangers, Applications of health-related quality of life for guiding health care: advances in response shift research, J Clin Epidemiol, vol.62, pp.1115-1122, 2009.

C. E. Schwartz and B. D. Rapkin, Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal, Health Qual Life Outcomes, vol.2, p.16, 2004.

C. E. Schwartz, R. Bode, N. Repucci, J. Becker, M. Sprangers et al., The clinical significance of adaptation to changing health: a meta-analysis of response shift, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.15, pp.1533-50, 2006.

B. D. Rapkin and C. E. Schwartz, Toward a theoretical model of quality-of-life appraisal: Implications of findings from studies of response shift, Health Qual Life Outcomes, vol.2, p.14, 2004.

G. Howard and P. Dailey, Response-shift bias: A source of contamination of self-report measures, J Appl Psychol, vol.64, pp.144-50, 1979.

I. S. Breetvelt and F. S. Van-dam, Underreporting by cancer patients: the case of response-shift, Soc Sci Med, vol.32, pp.981-988, 1982.

M. Sprangers and C. E. Schwartz, Integrating response shift into health-related quality of life research: a theoretical model, Soc Sci Med, vol.48, pp.1507-1522, 1999.

R. Barclay-goddard, J. D. Epstein, and N. E. Mayo, Response shift: a brief overview and proposed research priorities, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.18, pp.335-381, 2009.

G. S. Howard, K. M. Ralph, N. A. Gulanick, S. E. Maxwell, D. W. Nance et al., Internal invalidity in pretest-posttest self-report evaluations and a re-evaluation of retrospective pretests, Appl Psychol Meas, vol.3, pp.1-23, 1979.

M. A. Sprangers, Response-shift bias: a challenge to the assessment of patients' quality of life in cancer clinical trials, Cancer Treat Rev, vol.22, pp.55-62, 1996.

S. Mcphail and T. Haines, Response shift, recall bias and their effect on measuring change in health-related quality of life amongst older hospital patients, Health Qual Life Outcomes, vol.8, p.65, 2010.

S. Nolte, G. R. Elsworth, A. J. Sinclair, and R. H. Osborne, Tests of measurement invariance failed to support the application of the "then-test, J Clin Epidemiol, vol.62, pp.1173-80, 2009.

C. E. Schwartz and M. Sprangers, Guidelines for improving the stringency of response shift research using the thentest, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.19, pp.455-64, 2010.

C. E. Schwartz and M. Sprangers, Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research, Soc Sci Med, vol.48, pp.1531-1579, 1999.

T. S. Dabakuyo, F. Guillemin, T. Conroy, M. Velten, D. Jolly et al., Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study, Qual Life Res, vol.22, pp.1-11, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00687542

A. M. Hickey, G. Bury, C. A. O'boyle, F. Bradley, O. Kelly et al., A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS, BMJ, vol.313, pp.29-33, 1996.

C. A. O'boyle, H. Mcgee, A. Hickey, K. O'malley, and C. R. Joyce, Individual quality of life in patients undergoing hip replacement, Lancet Lond Engl, vol.339, pp.1088-91, 1992.

A. L. Edwards, Techniques of attitude scale construction, 1957.

C. E. Schwartz, Preference value assessment: card sort approach, Front Sci Technol Found, 1996.

I. J. Korfage, T. Hak, H. J. De-koning, and M. Essink-bot, Patients' perceptions of the side-effects of prostate cancer treatment--a qualitative interview study, Soc Sci Med, vol.63, pp.911-920, 1982.

S. Ahmed, N. E. Mayo, M. Corbiere, S. Wood-dauphinee, J. Hanley et al., Change in quality of life of people with stroke over time: true change or response shift?, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.14, pp.611-638, 2005.

N. Schmitt, The Use Of Analysis Of Covariance Structures To Assess Beta And Gamma Change, Multivar Behav Res, vol.17, pp.343-58, 1982.

N. Schmitt, E. D. Pulakos, and A. Lieblein, Comparison of Three Techniques to Assess Group-Level Beta and Gamma Change , Comparison of Three Techniques to Assess Group-Level Beta and Gamma Change, Appl Psychol Meas, vol.8, pp.249-60, 1984.

J. Schaubroeck and S. G. Green, Confirmatory Factor Analytic Procedures for Assessing Change During Organizational Entry, J Appl Psychol, vol.74, pp.892-900, 1989.

P. K. Gandhi, L. D. Ried, I. Huang, C. L. Kimberlin, and T. L. Kauf, Assessment of response shift using two structural equation modeling techniques, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.22, pp.461-71, 2013.

F. J. Oort, Using structural equation modeling to detect response shifts and true change, Qual Life Res, vol.14, pp.587-98, 2005.

S. Ahmed, J. Bourbeau, F. Maltais, and A. Mansour, The Oort structural equation modeling approach detected a response shift after a COPD self-management program not detected by the Schmitt technique, J Clin Epidemiol, vol.62, pp.1165-72, 2009.

L. M. Lix, T. T. Sajobi, R. Sawatzky, J. Liu, N. E. Mayo et al., Relative importance measures for reprioritization response shift, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.22, pp.695-703, 2013.

C. E. Schwartz, T. T. Sajobi, L. M. Lix, B. R. Quaranto, and J. A. Finkelstein, Changing values, changing outcomes: the influence of reprioritization response shift on outcome assessment after spine surgery, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.22, pp.2255-64, 2013.

A. Anota, C. Bascoul-mollevi, T. Conroy, F. Guillemin, M. Velten et al., Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients, Health Qual Life Outcomes, vol.12, p.32, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00997569

G. H. Fischer and I. W. Molenaar, Rasch Models: Foundations, Recent Developments, and Applications, 1995.

A. Guilleux, M. Blanchin, A. Vanier, F. Guillemin, B. Falissard et al., RespOnse Shift ALgorithm in Item response theory (ROSALI) for response shift detection with missing data in longitudinal patient-reported outcome studies, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.24, pp.553-64, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01815975

Z. Hamidou, T. S. Dabakuyo, and F. Bonnetain, Impact of response shift on longitudinal quality-oflife assessment in cancer clinical trials, Expert Rev Pharmacoecon Outcomes Res, vol.11, pp.549-59, 2011.

A. K. Kvam, F. Wisløff, and P. M. Fayers, Minimal important differences and response shift in healthrelated quality of life; a longitudinal study in patients with multiple myeloma, Health Qual Life Outcomes, vol.8, p.79, 2010.

Z. Hamidou, T. S. Dabakuyo, and F. Bonnetain, Impact of response shift on longitudinal quality-oflife assessment in cancer clinical trials, Expert Rev Pharmacoecon Outcomes Res, vol.11, pp.549-59, 2011.

M. Kosinski, S. Z. Zhao, S. Dedhiya, J. T. Osterhaus, and J. E. Ware, Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis, Arthritis Rheum, vol.43, pp.1478-87, 2000.

R. D. Crosby, R. L. Kolotkin, and G. R. Williams, An integrated method to determine meaningful changes in health-related quality of life, J Clin Epidemiol, vol.57, pp.1153-60, 2004.

A. Rouquette, M. Blanchin, V. Sébille, F. Guillemin, S. M. Côté et al., The minimal clinically important difference determined using item response theory models: an attempt to solve the issue of the association with baseline score, J Clin Epidemiol, vol.67, pp.433-473, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00936664

J. M. Norquist, R. Fitzpatrick, and C. Jenkinson, Health-related quality of life in amyotrophic lateral sclerosis: determining a meaningful deterioration, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.13, pp.1409-1423, 2004.

K. W. Wyrwich, N. A. Nienaber, W. M. Tierney, and F. D. Wolinsky, Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life, Med Care, vol.37, pp.469-78, 1999.

H. Beckerman, M. E. Roebroeck, G. J. Lankhorst, J. G. Becher, P. D. Bezemer et al., Smallest real difference, a link between reproducibility and responsiveness, Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.10, pp.571-579, 2001.

M. Verdam, F. J. Oort, and M. Sprangers, Using structural equation modeling to detect response shifts and true change in discrete variables: an application to the items of the SF-36, Qual Life Res, vol.25, pp.1361-83, 2016.

F. J. Oort, M. Visser, and M. Sprangers, An application of structural equation modeling to detect response shifts and true change in quality of life data from cancer patients undergoing invasive surgery, Qual Life Res, vol.14, pp.599-609

, Modèles à équations structurelles pour caractériser l'occurrence de la « Response-Shift » dans l'évaluation longitudinale de la qualité de vie relative à la santé | Request PDF

. Researchgate, , 2018.